Vast quantities of information can be gained from blood samples today using modern testing methods. The process for evaluating this hoard of data is equally complex as is the ability to draw reliable conclusions from it to diagnose diseases. Researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and biotech company BioVariance are hoping to develop new processes from…
/FAU Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
